Lyme and Co-Infection Nosode

Wirkstoff: ANGELICA ARCHANGELICA ROOT, POTASSIUM CHLORIDE, YUCCA FILAMENTOSA, SUS SCROFA CARTILAGE, PHYTOLACCA AMERICANA ROOT, GOLDENSEAL, TOXICODENDRON PUBESCENS LEAF, CAUSTICUM, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE, MANGANESE, OXALIC ACID, ARNICA MONTANA, BABESIA MICROTI, BORRELIA BURGDORFERI, LATRODECTUS MACTANS, ANHYDROUS CITRIC ACID, HUMAN HERPESVIRUS 5, RICKETTSIA PROWAZEKII, CHLAMYDIA TRACHOMATIS, LEDUM PALUSTRE TWIG

Flüssigkeit [Übersetzung der Form; Original: LIQUID (openFDA)] · ANGELICA ARCHANGELICA ROOT 2 [hp_X]/mL, POTASSIUM CHLORIDE 3 [hp_X]/mL, YUCCA FILAMENTOSA 3 [hp_X]/mL, SUS SCROFA CARTILAGE 4 [hp_X]/mL, PHYTOLACCA AMERICANA ROOT 4 [hp_X]/mL, GOLDENSEAL 5 [hp_X]/mL, TOXICODENDRON PUBESCENS LEAF 6 [hp_X]/mL, CAUSTICUM 6 [hp_X]/mL, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE 8 [hp_X]/mL, MANGANESE 8 [hp_X]/mL, OXALIC ACID 8 [hp_X]/mL, ARNICA MONTANA 8 [hp_X]/mL, BABESIA MICROTI 12 [hp_X]/mL, BORRELIA BURGDORFERI 12 [hp_X]/mL, LATRODECTUS MACTANS 12 [hp_X]/mL, ANHYDROUS CITRIC ACID 6 [hp_C]/mL, HUMAN HERPESVIRUS 5 6 [hp_C]/mL, RICKETTSIA PROWAZEKII 8 [hp_C]/mL, CHLAMYDIA TRACHOMATIS 12 [hp_C]/mL, LEDUM PALUSTRE TWIG 30 [hp_C]/mL

Vereinigte Staaten·Aktiv

Zulassungsinhaber: Bhp Holdings, Inc.

Geprüft 2026-10-09 · openFDA NDC